Dan Cannon

Dan Cannon is a Principal Application Scientist at Schrödinger, with prior experience as a Senior Application Scientist at the same company. Previously, Dan worked as a Scientist I and Associate Scientist II at MedImmune and served as a Postgraduate Researcher at the University of Strathclyde, focusing on advanced computational methods for biochemical simulation. Early career experience includes a role as a Development Scientist at ARTIS and a Research Chemist position at Cytec Engineered Materials, which involved a one-year industrial placement. Dan's research emphasizes benzoxazine materials, complementing a BSc (Hons) in Chemistry from the University of Strathclyde.